40843-81-0

Upstream product

• 40843-56-9 4-(3,4-Dichlorphenoxy)-anisol 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 459-57-4 4-fluorobenzaldehyde 
• 95-77-2 3,4-dichlorophenol 
• 78725-50-5 4-(3,4-dichloro-phenoxy)-benzaldehyde 

Downstream Products

• 51338-13-7 2-[4-(3,4-Dichloro-phenoxy)-phenoxy]-propionic acid isopropyl ester 
• 51338-28-4 2-[4-(2,4-Dichloro-phenoxy)-phenoxy]-propionic acid propyl ester 
• 51338-07-9 2-[4-(2,4-Dichloro-phenoxy)-phenoxy]-propionic acid isobutyl ester 
• 51338-29-5 2-[4-(2,4-Dichloro-phenoxy)-phenoxy]-propionic acid butyl ester 
• 51338-08-0 4-Amino-2-[4-(2,4-dichloro-phenoxy)-phenoxy]-butyric acid 
• 40843-41-2 [4-(2,4-Dichloro-phenoxy)-phenoxy]-phenyl-acetic acid 
• 51338-06-8 D-(+)-2-[4-(2,4-dichlorophenoxy)-phenoxy]-propionic acid ethyl ester 
• 40843-34-3 2-[4-(3,4-Dichloro-phenoxy)-phenoxy]-propionic acid 
• 606966-72-7 (3-{3-[4-(3,4-dichloro-phenoxy)-2-propyl-phenoxy]-propoxy}-phenyl)-hydroxy-acetic acid methyl ester 
• 606966-84-1 4-(3,4-dichloro-phenoxy)-2-propyl-phenol 
• 606966-78-3 4-(4-Allyloxy-phenoxy)-1,2-dichloro-benzene 
• 51338-10-4 [4-(2,4-Dichloro-phenoxy)-phenoxy]-acetic acid 

Relevant academic research and scientific papers

5-Aryl thiazolidine-2,4-diones: Discovery of PPAR dual α/γ agonists as antidiabetic agents

A novel series of 5-aryl thiazolidine-2,4-diones based dual PPARα/γ agonists was identified. A number of highly potent and orally bioavailable analogues were synthesized. Efficacy study results of some of these analogues in the db/db mice model of type 2 diabetes showed them superior to rosiglitazone in correcting hyperglycemia and hypertriglyceridemia.